The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

A manufacturing method of a housing includes the following steps: a preformed housing is provided. The preformed housing includes a body and a sidewall connected to the edge of the body, and a decoration film disposed on the body and the sidewall. A portion of the sidewall is exposed from the decoration film. The body includes a first surface. The sidewall includes a second surface. The second surface extends from the first surface. The first surface and the second surface are non-coplanar. A decoration layer is formed on the exposed portion of the sidewall by a surface processing treatment.

A process for the production of composite materials at low temperatures, as well as a composite material obtained by the process and articles of manufacture comprising the composite material are provided.

Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

A reinforcing article includes a porous substrate layer separating a plurality of parallel first continuous fiber elements spaced apart from each other and extending along a first direction from a plurality of parallel second continuous fiber elements spaced apart from each other and extending along a different direction. Each first and second continuous fiber elements include a plurality of parallel and co-extending continuous fibers embedded in a thermoplastic resin.

Provided is a method of producing a film by cryogenically grinding polypropiolactone to form a powder, and extruding the powder to form the film. Provided herein are also polypropiolactone films having certain biocontent and compostability, as well as certain mechanical and physical properties. Such films may also be suitable for use as packaging materials.

A 3-D printed device comprising one or more structures, the structures comprising a plurality of magnetically responsive particles and one or more diblock or triblock copolymers; the diblock or triblock copolymers having an A-B, A-B-A, or A-B-C block-type structure in which the A-blocks and C-blocks are an aromatic-based polymer or an acrylate-based polymer and the B-blocks are an aliphatic-based polymer. These 3-D printed devices may be formed using a method that comprises providing a magnetic ink composition; applying the magnetic ink composition to a substrate in a 3-D solvent cast printing process to form one or more structures; and drying the one or more structures formed from the magnetic ink composition. The dried structures can exhibit one or more regions of magnetic permeability greater than 1.310.sup.6 H/m.

The present disclosure is directed to systems and methods for synthesizing a spidroin. In some embodiments, the methods comprise synthesizing a monomer in vivo in a heterologous host, the monomer comprising an N-terminus IntC domain and a C-terminus IntN domain, and post-translationally polymerizing the synthesized monomer via in vitro split-intein mediated polymerization.

The present invention relates to a method for evaluating an injection physical property of a plastic resin, and a polyethylene resin suitable for an injection molding process and, more particularly, to a novel method for evaluating an injection physical property of a plastic resin, which, when a particular plastic resin is processed by an injection process, can accurately derive injection suitability of the plastic resin and injection pressure in the injection process through a physical property value measured by using a resin specimen, and a polyethylene resin suitable for injection molding.